Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell trans...

por Zhou, Ling, Lu, Dao-pei
Publicado 2019

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical h...

por Zhou, Ling, Gao, Zhi-yong, Lu, Dao-pei
Publicado 2020

Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells

por LIU, JIN HONG, BIAN, YONG MEI, XIE, YI, LU, DAO PEI
Publicado 2015

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemother...

por Zhao, Yan-Li, Liu, De-Yan, Sun, Rui-Juan, Zhang, Jian-Ping, Zhou, Jia-Rui, Wei, Zhi-Jie, Xiong, Min, Cao, Xing-Yu, Lu, Yue, Yang, Jun-fang, Zhang, Xian, Lu, Dao-Pei, Lu, Peihua
Publicado 2021

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation...

por Lu, Yue, Zhang, Jian-Ping, Zhao, Yan-Li, Xiong, Min, Sun, Rui-Juan, Cao, Xing-Yu, Wei, Zhi-Jie, Zhou, Jia-Rui, Liu, De-Yan, Yang, Jun-Fang, Zhang, Xian, Lu, Dao-Pei, Lu, Peihua
Publicado 2023

Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group

por Xu, Lan-Ping, Lu, Dao-Pei, Wu, De-Pei, Jiang, Er-Lie, Liu, Dai-Hong, Huang, He, Sun, Zi-Min, Li, Nai-Nong, Liu, Qi-Fa, Zhang, Xi, Lai, Yong-Rong, Song, Yong-Ping, Song, Xian-Min, Liu, Si-Xi, Zhang, Yi-Cheng, Luo, Cheng-Juan, Xia, Ling-Hui, Niu, Ting, Yu, Yu, Zhang, Xiao-Hui, Tang, Xiao-Wen, Luo, Yi, Huang, Xiao-Jun
Publicado 2023